Nitoprusside, dopamine and dobutamine for treatment of refractory heart failure
10.3760/cma.j.issn.1008-6706.2010.17.016
- VernacularTitle:硝普钠、多巴胺及多巴酚丁胺联合治疗顽固性心力衰竭30例分析
- Author:
Qiang LIU
;
Yongbin XU
- Publication Type:Journal Article
- Keywords:
Dopamine;
dobutamine;
Sodium nitroprusside;
Heart failure
- From:
Chinese Journal of Primary Medicine and Pharmacy
2010;17(17):2336-2337
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical effect of nitroprusside,dopamine and dobutamine for treatment of refractory heart failure. Methods 60 patients with refractory heart failure were randomly divided into control group and treatment group. Clinical symptoms, signs, echocardiography and other changes were observed. Results The total effective rate was 86.67% ,control group was 66.67% ,the total effective between the two groups was statistically significant(P ＜ 0.05). After treatment, left ventricular ejection fraction (LVEF) improved significantly compared with the control group, the difference was statistically significant(P ＜ 0.05). Conclusion The Sodium nitroprusside, dopamine and dobutamine for treatment of refractory heart failure was safe and effective method.
